Mironid® Limited

Mironid Limited, founded in 2014, is an innovative biotechnology startup based in the United Kingdom. The company's slogan, "Mobkoi specializes in premium mobile marketing using rich media, video, and display to reach premium audiences," reflects its focus on premium mobile marketing in the industries of biotechnology, health care, health and wellness, and marketing. Mironid's groundbreaking work lies in developing proprietary drug candidate molecules by modulating the activity of key cell signaling proteins, allowing access to multiple therapeutic areas for exploitation. The company's current drug discovery pipeline aims to develop novel treatments for degenerative kidney diseases, chronic inflammatory diseases, and cancer. Mironid recently secured a significant Series A investment of £30.70M on 13 September 2023, with the support of notable investors including Sofinnova Partners, BioGeneration Ventures, Scottish Enterprise, EIF, Epidarex Capital, Roche Venture Fund, and the University of Strathclyde. This investment marks a pivotal moment in the company's journey, enabling it to advance its cutting-edge research and propel its mission to revolutionize healthcare through innovative drug discovery.